Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses ; volume:30 ; number:4 ; day:19 ; month:3 ; year:2024 ; pages:1023-1034 ; date:4.2024
Nature medicine ; 30, Heft 4 (19.3.2024), 1023-1034, 4.2024
- Urheber
-
Kelly, Ronan J.
Landon, Blair V.
Zaidi, Ali H.
Singh, Dipika
Canzoniero, Jenna V.
Balan, Archana
Hales, Russell K.
Voong, K. Ranh
Battafarano, Richard J.
Jobe, Blair A.
Yang, Stephen C.
Broderick, Stephen
Ha, Jinny
Marrone, Kristen A.
Pereira, Gavin
Rao, Nisha
Borole, Aryan
Karaindrou, Katerina
Belcaid, Zineb
White, James R.
Ke, Suqi
Amjad, Ali I.
Weksler, Benny
Shin, Eun Ji
Thompson, Elizabeth
Smith, Kellie N.
Pardoll, Drew M.
Hu, Chen
Feliciano, Josephine L.
Anagnostou, Valsamo
Lam, Vincent K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-024-02877-z
- URN
-
urn:nbn:de:101:1-2407012122031.613976890331
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kelly, Ronan J.
- Landon, Blair V.
- Zaidi, Ali H.
- Singh, Dipika
- Canzoniero, Jenna V.
- Balan, Archana
- Hales, Russell K.
- Voong, K. Ranh
- Battafarano, Richard J.
- Jobe, Blair A.
- Yang, Stephen C.
- Broderick, Stephen
- Ha, Jinny
- Marrone, Kristen A.
- Pereira, Gavin
- Rao, Nisha
- Borole, Aryan
- Karaindrou, Katerina
- Belcaid, Zineb
- White, James R.
- Ke, Suqi
- Amjad, Ali I.
- Weksler, Benny
- Shin, Eun Ji
- Thompson, Elizabeth
- Smith, Kellie N.
- Pardoll, Drew M.
- Hu, Chen
- Feliciano, Josephine L.
- Anagnostou, Valsamo
- Lam, Vincent K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France
Myofasziitis unter Nivolumab-Therapie
Nivolumab induced myxedema crisis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France
Myofasziitis unter Nivolumab-Therapie
Nivolumab induced myxedema crisis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France
Myofasziitis unter Nivolumab-Therapie